Latest Racing News

Great Northern Minerals has significantly expanded its Catalyst Ridge rare earth and antimony project in California’s Mountain Pass District by applying for 96 additional lode claims, positioning itself strongly within a critical US minerals hub.

Jindalee Lithium has signed a non-binding LOI to merge its US lithium assets with a US SPAC, aiming to list on a national exchange and unlock significant funding for its McDermitt Project.

Augustus Minerals is progressing its second-in-time licence application for the Mt Kare Gold Project in Papua New Guinea, aiming to unlock a high-grade alkali epithermal deposit near the Porgera mine. The company is preparing for rapid underground development and aggressive drilling, contingent on regulatory outcomes.

Race Oncology has activated its first clinical trial site in Hong Kong for the Phase 1 study of RC220 combined with doxorubicin in advanced solid tumours, marking a significant step in accelerating patient enrolment and broadening clinical data.

Redcastle Resources has significantly expanded its exploration footprint in Western Australia’s Leonora–Laverton goldfields through the acquisition of the TBone Belt tenements, adding multiple promising near-surface targets adjacent to its existing projects.

Castle Minerals has acquired the remaining 10% of Mineralis Ltd, gaining 100% ownership and exclusive rights to explore seven gold permits in Côte d’Ivoire. This strategic move positions Castle to accelerate exploration in a highly prospective West African gold region backed by committed funding and leadership upgrades.

MIXI Australia has secured majority voting power in PointsBet, pushing the takeover offer deadline to mid-September and setting the stage for full control.

Memphasys Limited reported a net loss of AUD 4.94 million for FY25 while accelerating commercial efforts for its Felix System and advancing its RoXsta diagnostics platform.

Clarity Pharmaceuticals reported a $64.3 million loss for FY2025 alongside significant clinical progress and a $203.6 million placement to fund its radiopharmaceutical pipeline expansion.

Airtasker Limited reported a robust FY25 with marketplaces revenue growth accelerating to 18.3%, positive free cash flow, and significant expansion in the UK and US markets. Strategic media partnerships and brand investments underpin this momentum as the company sets sights on further growth in FY26.

RAS Technology Holdings Limited reported a robust 31% increase in revenue to A$21.3 million for FY25, alongside its first net profit after tax since listing, driven by strategic acquisitions and global expansion.

RAS Technology Holdings reports a robust 31% revenue increase in FY25, marking its second consecutive profitable year, driven by strategic acquisitions and global partnerships that position it for sustained growth.